Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00149721 · ClinicalTrials.gov registry record · NA
Anterior Pituitary Function in Patients With Hydrocephalus
A NA study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT00149721: Clinical Trial NA study, sponsored by Johns Hopkins University.
NCT00149721 is a NA study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00149721, a NA study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
Hydrocephalus (secondary or idiopathic) is a condition characterized by dilatation of the lateral and third ventricles, and often associated with increased intracranial pressure (ICP). We hypothesize that either the ventricle dilatation or the increased ICP may cause disturbances in the hypothalamic-pituitary axis, resulting in different degrees of hypopituitarism. The goal of this study is to determine the prevalence of hypopituitarism in adult patients with hydrocephalus.
Interventions
- PROCEDURE Ventriculo-peritonal shunting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2005-09 |
| Est. Completion | 2007-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00149721
The ClinicalTrials.gov registry entry for NCT00149721 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ventriculo-peritonal shunting is the first listed.
NCT00149721 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00149721 about?
NCT00149721 is a clinical study titled "Anterior Pituitary Function in Patients With Hydrocephalus". Hydrocephalus (secondary or idiopathic) is a condition characterized by dilatation of the lateral and third ventricles, and often associated with increased intracranial pressure (ICP). We hypothesize that either the ventricle dilatation or the increased ICP may cause disturbances in the hypothalamic...
What is the current status of trial NCT00149721?
This trial is currently terminated. It is a NA study. The enrollment target is 30 participants. The study started on 2005-09. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00149721?
The interventions under investigation include: Ventriculo-peritonal shunting (PROCEDURE).
Who is sponsoring clinical trial NCT00149721?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.